Two-Year Safety and Efficacy Experience in Patients with Methotrexate-Resistant Active Rheumatoid Arthritis Treated with Etanercept and Conventional Disease-Modifying Anti-rheumatic Drugs in the Latin American Region

DOI: 10.2174/1874312901610010013

Keywords: Disease-modifying antirheumatic drugs, etanercept, Latin America, methotrexate, rheumatoid arthritis

Full-Text   Cite this paper   Add to My Lib

Abstract:

Although long-term data are available from biologic studies in North American/European populations with rheumatoid arthritis (RA), long-term findings in Latin American RA populations are limited

Full-Text